P.A. Sharp, Split Genes and RNA splicing nobel lecture, (1994)
D. Li, W. Yu, M. Lai, Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing. Elsevier Ltd (Sep 01 2023). https://doi.org/10.1016/j.drudis.2023.103691
E.T. Wang et al., Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221), 470–476 (2008). https://doi.org/10.1038/nature07509
Article CAS PubMed PubMed Central Google Scholar
J. Tian et al., Aberrant RNA splicing is a primary link between genetic variation and pancreatic cancer risk. Cancer. Res. 82(11), 2084–2096 (2022). https://doi.org/10.1158/0008-5472.CAN-21-4367
Article CAS PubMed Google Scholar
F.E. Baralle, J. Giudice, Alternative splicing as a regulator of development and tissue identity. Nat. Pub. Group 1 (Jul. 01, 2017). https://doi.org/10.1038/nrm.2017.27
J.L. Hervoso et al., Splicing-specific transcriptome-wide association uncovers genetic mechanisms for schizophrenia. Am. J. Hum. Genet 111(8), 1573–1587 (2024). https://doi.org/10.1016/j.ajhg.2024.06.001
Article CAS PubMed PubMed Central Google Scholar
B.R. Graveley, T. Maniatis, Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol. Cell 1(5), 765–771 (1998). https://doi.org/10.1016/S1097-2765(00)80076-3
Article CAS PubMed Google Scholar
T. Wang et al., Arabidopsis SRPKII family proteins regulate flowering via phosphorylation of SR proteins and effects on gene expression and alternative splicing. New. Phytol. 238(5), 1889–1907 (2023). https://doi.org/10.1111/NPH.18895
Article CAS PubMed Google Scholar
X. Li, J.L. Manley, Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122(3), 365–378 (2005). https://doi.org/10.1016/J.CELL.2005.06.008
Article CAS PubMed Google Scholar
M. Müller-McNicoll et al., SR proteins are NXF1 adaptors that link alternative RNA processing to mRNA export. Genes Dev. 30(5), 553–566 (2016). https://doi.org/10.1101/GAD.276477.115/-/DC1
Article PubMed PubMed Central Google Scholar
R.E. Wagner, M. Frye, Noncanonical functions of the serine-arginine-rich splicing factor (SR) family of proteins in development and disease. BioEssays 43(4), 2000242 (2021). https://doi.org/10.1002/BIES.202000242
S.M. Cascarina, E.D. Ross, Expansion and functional analysis of the SR-related protein family across the domains of life. RNA 28(10), 1298–1314 (2022). https://doi.org/10.1261/RNA.079170.122/-/DC1
Article CAS PubMed PubMed Central Google Scholar
J.X. Du et al., Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. J. Exp. Clin. Cancer Res. 40 (2021). https://doi.org/10.1186/s13046-021-01978-8
X. Wang et al., SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. J. Transl. Med 20(1), 1–18 (2022). https://doi.org/10.1186/S12967-022-03399-3/FIGURES/6
Article PubMed PubMed Central Google Scholar
J. Larrasa-Alonso et al., The SRSF4-GAS5-glucocorticoid receptor axis regulates ventricular hypertrophy. Circ. Res 129(6), 669–683 (2021). https://doi.org/10.1161/CIRCRESAHA.120.318577/SUPPL_FILE/CIRCRES_CIRCRES-2020-318577D_SUPP8.PDF
Article CAS PubMed PubMed Central Google Scholar
J. Xiong, Y. Chen, W. Wang, J. Sun, Biological function and molecular mechanism of SRSF3 in cancer and beyond. Oncol. Lett 23(1), 21 (2021). https://doi.org/10.3892/OL.2021.13139
Article PubMed PubMed Central Google Scholar
D. Segovia et al., SRSF1 interactome determined by proximity labeling reveals direct interaction with spliceosomal RNA helicase DDX23. Proc. Natl. Acad. Sci. U. S. A. 121(21), e2322974121 (2024). https://doi.org/10.1073/PNAS.2322974121/SUPPL_FILE/PNAS.2322974121.SD01.XLSX
Article CAS PubMed PubMed Central Google Scholar
M. Bei, J. Xu, SR Proteins in Cancer: function, Regulation, and Small Inhibitor. BioMed. Central. Ltd (2024)https://doi.org/10.1186/s11658-024-00594-6
J.C. Long, J.F. Caceres, The SR Protein Family of Splicing Factors: master Regulators of Gene Expression (2009). https://doi.org/10.1042/BJ20081501
Y. Che, L. Fu, Aberrant expression and regulatory network of splicing factor-SRSF3 in tumors. Ivyspring Int. Publisher (2020). https://doi.org/10.7150/jca.42645
N.K. Leclair et al., Poison exon splicing regulates a coordinated network of SR protein expression during differentiation and Tumorigenesis. Mol. Cell 80(4), 648–665.e9 (2020). https://doi.org/10.1016/j.molcel.2020.10.019
Article CAS PubMed PubMed Central Google Scholar
M.A. Rahman, A.R. Krainer, O. Abdel-Wahab, SnapShot: splicing alterations in cancer. Cell. Press (2020). https://doi.org/10.1016/j.cell.2019.12.011
M. Song, L. Pang, M. Zhang, Y. Qu, K.V. Laster, Z. Dong, Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases. Springer Nature (2023). https://doi.org/10.1038/s41392-023-01409-4
B.E. Aubol et al., Release of SR proteins from CLK1 by SRPK1: a symbiotic kinase System for phosphorylation control of pre-mRNA splicing. Mol. Cell 63(2), 218–228 (2016). https://doi.org/10.1016/J.MOLCEL.2016.05.034
Article CAS PubMed PubMed Central Google Scholar
B.E. Aubol, P. Serrano, L. Fattet, K. Wüthrich, J.A. Adams, Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1. J. Biol. Chem. 293(43), 16751–16760 (2018). https://doi.org/10.1074/JBC.RA118.004587
Article CAS PubMed PubMed Central Google Scholar
K. Jiang et al., Akt2 regulation of Cdc2-like kinases (Clk/Sty), Serine/Arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCβII messenger ribonucleic acid. Endocrinology 150(5), 2087–2097 (2009). https://doi.org/10.1210/EN.2008-0818
X.Y. Zhong, J.H. Ding, J.A. Adams, G. Ghosh, X.D. Fu, Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 23(4), 482–495 (2009). https://doi.org/10.1101/GAD.1752109
Article CAS PubMed PubMed Central Google Scholar
C.T. Ma, G. Ghosh, X.D. Fu, J.A. Adams, Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1. J. Mol. Biol. 403(3), 386–404 (2010). https://doi.org/10.1016/J.JMB.2010.08.024
Article CAS PubMed PubMed Central Google Scholar
S. Chen et al., CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer. J. Hematol. Oncol. 14 (2021). https://doi.org/10.1186/s13045-021-01072-8
Y. Goldtzvik, N. Sen, S.D. Lam, C. Orengo, Protein Diversification Through Post-Translational Modifications, Alternative Splicing, and Gene Duplication. Elsevier Ltd (2023)https://doi.org/10.1016/j.sbi.2023.102640
V. Edmond et al., Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. Embo. J. 30(3), 510–523 (2011). https://doi.org/10.1038/EMBOJ.2010.333/SUPPL_FILE/EMBJ2010333.REVIEWER_COMMENTS.PDF
Article CAS PubMed Google Scholar
S.C. Larsen et al., Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells. Sci. Signal 9(443). (2016). https://doi.org/10.1126/SCISIGNAL.AAF7329/SUPPL_FILE/9_RS9_TABLES_S1_TO_S5.ZIP
W. Lan, Y. Qiu, Y. Xu, Y. Liu, Y. Miao, Ubiquitination and ubiquitin-like modifications as mediators of alternative pre-mRNA splicing in Arabidopsis thaliana. Front. Plant. Sci. 13, 869870 (2022). https://doi.org/10.3389/FPLS.2022.869870/BIBTEX
Article CAS PubMed PubMed Central Google Scholar
M.L. Morales et al., Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia. Leukemia 37(8), 1649–1659 (2023). https://doi.org/10.1038/s41375-023-01963-4
Article CAS PubMed PubMed Central Google Scholar
Y. Long et al., Distinct mechanisms govern the phosphorylation of different SR protein splicing factors. J. Biol. Chem. 294(4), 1312–1327 (2019). https://doi.org/10.1074/jbc.RA118.003392
Comments (0)